AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04236999 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Yo Sé Lo Que Quiero (YSLQQ)
Description: This program is organized in 12 sessions around three themes:~* Knowledge and attitudes (sessions 1, 3, 5 and 9): Students reflect on their knowledge of legal and illegal drugs, using critical thinking to obtain an objective assessment of this knowledge.~* Intrapersonal skills (sessions 4, 6, 8, 10. 11. and 12): Activities are carried out where students can put themselves in everyday situations and develop skills such as assertiveness, problem solving, among others.~* Interpersonal skills (sessions 2 and 7): Students are instructed to practice refusal skills, assertiveness, and analyze coping strategies.
Study NCT06362382 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: tele-rehabilitation training
Description: During their stay in the hospital, the patients were accompanied by a rehabilitation trainer and a psychotherapist for a complete cycle of (7 days ± 3 days 1 week/times) standardized training.~After discharge from the hospital, patients in the rehabilitation group underwent 3-5 weekly daily （a total of 3 months）training sessions and intensive supervision and management by the online community at least once a week. All patients' routines were monitored by telemetry and data, photographs and video recordings were collected by a specialized agency.~The scheme of rehabilitation is impedance training. A specialized professional team including cardiologists, rehabilitation trainers, psychotherapists and radiologists were involved.
Study NCT06362382 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: health propaganda and education
Description: During their stay in the hospital, participants of the control group received health propaganda and education (7 days ± 3 days 1 week/times).~After discharge from the hospital, the control group followed their daily routine.
Study NCT04209894 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Ultrasound
Description: Evaluation consisted of the detection of grey scale (GS) enthesitis and Power Doppler signal in enthesis areas of participants. The Madrid Sonography Enthesitis Index (MASEI) scoring system was used to quantify the extent of sonographic entheseal abnormalities
Study NCT04736563 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Joint and muscle gel Puressentiel
Description: To evaluate the antalgic effect in patients with chronic pain related to osteoarthritis of the knee when applied to the skin of Puressentiel Joints and Muscles - Gel with 14 essential oils.
Study NCT05762159 — intervention group
Intervention type: OTHER
Intervention: data collected
Description: data collected:~* Morphological data of the patients~* Data of the erector block realization~* Pupillometric data :the variation of the pupil size on stimulation (in percentage of the base diameter)
Study NCT06506656 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hyadrol®
Description: Sterile single-use Medical Device for intra-articular injections
Study NCT04707092 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Antibiotic
Description: Antibiotic in case of now allergies will be Cefazolin at induction and Amoxicillin plus Clavulanic acid for the oral treatment week
Study NCT05090618 — intervention group
Intervention type: GENETIC
Intervention: DNA analysis
Description: GWAS
Study NCT05178186 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Thyroidectomy
Description: Surgery for thyroid carcinoma
Study NCT06361134 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SAFE Early İntervention
Description: As part of the intervention, sensory-based intervention was applied in an enriched environment. In the home setting, physiotherapists collaborated with the family to advance the intervention. The intervention was revised by making monthly home visits to infants with a corrected age of 42 weeks.
Study NCT06361134 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: NDT based therapy
Description: Neuromotor evaluations of the babies were performed in a clinical setting. The rehabilitation program to be implemented was given to the family as a booklet. The programs of the children examined in the clinic every month were revised.
Study NCT05365100 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BN102
Description: oral tablets: BN102, BID
Study NCT04698148 — intervention group
Intervention type: OTHER
Intervention: Biological sample collection
Description: Collection of faeces, coproculture examination, urine, saliva, PBMC and blood for biobanking, to evaluate the proteomic, metascriptomic, metabolomic, metagenomic, and metagenetic profile, and to perform routine screening. Analysis for the identification, quantification and characterization of health-promoting bacteria
Study NCT04698148 — intervention group
Intervention type: OTHER
Intervention: Questionnaire
Description: Anamnestic questionnaire, 3-day food questionnaire, Food Frequency Questionnaire
Study NCT04698148 — intervention group
Intervention type: OTHER
Intervention: Medical examination
Description: Blood pressure measurement, abdominal and thoracic physical examination
Study NCT04946565 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Semen analysis
Description: Semen analysis according to WHO laboratory manual for the examination and processing of human semen, Fifth edition
Study NCT06176482 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Magnetic markers implantation
Description: Surgical implantation of magnetic markers in the upper limb stump to allow the management of an external hand prosthesis
Study NCT05434819 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surgical Atrial Fibrillation Ablation
Description: Surgeon will preform surgical atrial fibrillation ablation using either cryoablation or bipolar radiofrequency clamps including 2 layers of atrium or vein, a minimum of 2 burns per clamping with at least 3 lines in the ablation group. Cavo-tricuspid isthmus and mitral lines will be allowed.
Study NCT05321485 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MedicijnWijs
Description: The mobile phone app MedicijnWijs will guide the participants with their azathioprine therapy during 6 weeks. Information about azathioprine is given as well as general information about IBD, specified to disease modality (Crohn's Disease and Ulcerative Colitis). Contact details of the patient's pharmacy are listed, questions about the patient's symptoms are asked, and push notifications are added to remind the patients to take their medication.~At the beginning of the 6-weeks guidance, two validated questionnaires that are translated and validated in Dutch will have to be filled in: the MARS-5 and the IBD-KID2. After 6 weeks, the participants have to fill out the same questionnaires again to assess potential changes in the scores compared to baseline. Also, a number of questions will be asked to assess the ease of use of MedicijnWijs.
Study NCT05198882 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Laser technology for intracerebral thermocoagulation
Description: One intervention : LITT (Laser Interstitial Thermal Treatment), technology that uses laser energy to thermally destroy (photo-thermal treatment) a brain injury under continuous MRI control (Validated by FDA - CE marking). The operator console + surgical laser generator + software that manages the power delivered by the laser is connected to an MRI - Provided by MEDTRONIC - FDA approved and CE certified.
Study NCT05161806 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SOK583A1 (40 mg/mL)
Description: SOK583A1 provided in a Prefilled Syringe (PFS), which includes 2 mg aflibercept in 0.05 mL for IVT administration
Study NCT05161806 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Prefilled Syringe (PFS)
Description: Prefilled Syringe (PFS)
Study NCT03653169 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation
Description: TMS is a form of noninvasive brain stimulation. An external electromagnetic coil is placed on the head, and a large current is passed through an insulated wire coil held flat on the surface of a subject's scalp in a fraction of a millisecond. This pulse of current induces a weak electrical current within the surface brain cortex. Repetitive trains of TMS pulses (repetitive TMS or rTMS) can transiently modulate corticospinal excitability following the rTMS train. When current is delivered at high frequency (10 Hz), it may simultaneously increase the activity of the brain at this site. In this study, individuals will receive 10 treatments with intermittent theta burst stimulation (twice daily for 5 days).
Study NCT04277715 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Parent training
Description: Parents will learn evidence-based techniques for increasing support and decreasing accommodation of children's chronic symptoms.
Study NCT01431586 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JDtic
Description: The planned JDTic dose levels to be evaluated are 1 mg, 3 mg, and 10 mg; however, the actual dose levels evaluated may be different, and/or additional dose levels may be added by protocol amendment, depending on the safety and PK results of the lower doses.~Subjects will be admitted to the clinic the day before dosing and will be confined to the clinic for 6 nights, with safety and PK evaluations and assessments lasting approximately 125 hours following administration of study drug.
Study NCT04901936 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pegcetacoplan
Description: Complement (C3) inhibitor
Study NCT05174130 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: RESPIRA device.com® Advanced
Description: Ventilation of patients with continuous monitoring of the patient's clinical parameters and the parameters that the investigational medical device shows.
Study NCT05628493 — intervention group
Intervention type: BEHAVIORAL
Intervention: Gut microbiota Analysis
Description: fecal samples were collected per patient on days 1,3 and 7 after ICU admission. All eligible patients were given antibiotics therapy, actively control infection source by puncture drainage or surgery if necessary, as well as other supportive therapy to maintain organ function.
Study NCT06159166 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mirdametinib
Description: This study is designed to assess Mirdametinib safety and efficacy in two phases: phase 1 tests the safety of up to four dose regimens of Mirdametinib, administered continuously or intermittently (3 weeks on/1 week off) to identify up to two recommended phase 2 doses. Phase 2a of the study will test the safety and efficacy of the recommended phase 2 dose(s) in adults with NF1 and cNF. The following dosing strategy will be assessed in participants ≥ 18 years old with NF1 and a minimum of 12 measurable cNF who desire systemic treatment of their cNF due to disfigurement, pain or itching. Each treatment cycle in this study is 28 days.treatment cycle in this study is 28 days.
Study NCT05454722 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ADEX Gel
Description: Emollient Gel with added anti-inflammatory
Study NCT05993507 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Problem Management Plus (PM+)
Description: Problem Management Plus (PM+) is a brief, scalable intervention that is developed by World Health Organization for communities exposed to adversity. PM+ consists of five weekly in-person sessions of 90 minutes. The intervention integrates four evidence-based behavioural strategies: arousal reduction using a slow breathing exercise (session 1), problem-solving (session 2), behavioural activation by re-engaging with pleasant and task-oriented activities (session 3) and accessing social support (session 4). Homework practice is scheduled following each session and discussed in the next session. Psychoeducation is delivered in session 1 and relapse prevention is discussed in session 5. Facilitators will receive weekly supervisions by PM+ supervisors.
Study NCT04779671 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: VR cognitive training
Description: All participants will receive trainings for 60 minutes per day, two days per week for 16 sessions.~They will receive one immersive leisure-based VR cognitive training for 30 minutes. VR cognitive training receives four gardening activities.~The cognitive elements including attention, working memory, processing speed, and executive function incorporated training.
Study NCT04779671 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Traditional cognitive training
Description: All participants will receive trainings for 60 minutes per day, two days per week for 16 sessions.~The control group is performing traditional cognitive training program.
Study NCT05751057 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Cardiovascular Magnetic Resonance
Description: All NSTEMI patients will undergo to CMR before invasive coronary intervention.
Study NCT05331430 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dry needling on cervical trigger point
Description: One experimental group will receive dry needling treatment on the upper trapezius fibres using the Hong technique and the other experimental group will receive passive muscle stretching treatment on the upper trapezius fibres.
Study NCT04799678 — intervention group
Intervention type: OTHER
Intervention: Recording voice samples
Description: A maximum of 9 voice sample recording session will be carried out on their phones and take less than 2 minutes each
Study NCT05715554 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Homeopathy
Description: Individualized homoeopathic medicines on impregnated lactose pellets was prescribed based on totality of physical, emotional, and mental symptoms.
Study NCT06231719 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cold Spray
Description: Using cold spray for injection site before the Anti-D immunglobulin injection. 2 sprays of cold spray are applied from a distance of 25 cm.
Study NCT05528146 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Psyllium huks
Description: psyllium in 250ml of water
Study NCT06335472 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: 3 nerves pulsed radiofrequency with hydrodissection
Description: Patient will be in a sitting position, targeting the SSN, needle will be pushed towards floor of the suprascapular fossa, SSN is just adjacent to the suprascapular artery.~The axillary nerve, between the deltoid muscle posteriorly, triceps muscle caudally and humerus anteriorly, axillary nerve appears as hyperechoic round in relation to posterior circumflex humeral artery.~Lateral pectoral nerve, middle of coracoid process should be targeted, lie within hyperechoic fascial plane between pectoralis major and pectoralis minor muscle.~hydrodissection, US transducer will be positioned inferior to scapular line , landmarks are contours of glenoid rim and humeral head, needle will be advanced until enter the GHJ capsule.~A solution composed of 3 mL of lidocaine 1%, 3 mL of bupivacaine 0.25%, and 1 mL of dexamethasone 40 mg, followed by infusion of up to 40 mL of normal saline, until capsule is adequately distended and resistance felt
Study NCT06335472 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: suprascapular nerve pulsed radiofrequency with hydrodissection
Description: The patient will be positioned in a sitting position, PRF needle will be pushed forward towards the floor of the suprascapular fossa the SSN will be visualized just adjacent to the suprascapular artery.~hydrodissection will be done under all aseptic measures ,the US transducer will be positioned just inferior to the scapular line , landmarks are contours of posterior glenoid rim and humeral head, needle will be advanced until the needle tip will enter the GHJ capsule.~A solution composed of 3 mL of lidocaine 1%, 3 mL of bupivacaine 0.25%, and 1 mL of dexamethasone 40 mg, followed by an infusion of up to 40 mL of normal saline , until the capsule is adequately distended and resistance will be felt.
Study NCT06461871 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: BALANCE TRAINING WITH MODERATE INTESITY AEROBIC VERSUS RESISTED TRAINING (RT)
Description: The duration of study is 6 months. Three to five sessions of both aerobic and resistance exercise training in combination with balance training are taken out per week . Each session lasting 15 minutes. GROUP A: Baseline treatment + Moderate intensity aerobic exercises in combination with balance training
Study NCT06461871 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Moderate intensity resistance exercises in combination with balance training
Description: The duration of study is 6 months. Three to five sessions of both aerobic and resistance exercise training in combination with balance training are taken out per week . Each session lasting 15 minutes. GROUP B: Baseline treatment + Moderate intensity resistance exercises in combination with balance training
Study NCT05237180 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: spatial localisation training
Description: 8 spatial localization training sessions MBAA and SSQ tests before and after training sessions.
Study NCT06241287 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Better Living with Non-memory led Dementia programme
Description: an 8-week duration 6-module educational programme covering the following topics: 1) Welcome to the programme and what to expect from it; 2) Understanding the disease; 3) How to provide better support for the person with dementia; 4) How to look after the caregiver's own mental health; 5) Where to find additional sources of support, and 6) An introduction to the value of support groups. At the end of modules 2, 3, and 4, participants will be asked to complete a real-life task to put in practice skills learned in the specific module (e.g., approaching a friend and explaining the disease in lay terms). The first session (onboarding) will be facilitated via Zoom by one of the members of the research team. Up to 3 total interactions between facilitators and participants will be offered to support participants' engagement with the programme. All course modules will be printable using the pdf download button on the programme's page.
Study NCT06241287 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Waiting list
Description: Signposting individuals to the publicly available Rare Dementia Support website. The control group will further receive access to the Better Living with Non-memory led Dementia programme after completing the collection of measures at 6 months.
Study NCT04986020 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: MRI
Description: Identification of novel biomarkers from MRI
Study NCT06231719 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Manuel Pressure
Description: Using manuel pressure ( about 10 second ) before the Anti-D immunglobulin injection.
Study NCT04899713 — intervention group
Intervention type: OTHER
Intervention: Survival survey
Description: To assess the effect of adding ZOMETA® to neoadjuvant chemotherapy on event-free survival.
Study NCT05902819 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Imagery
Description: Guided imagery of personal trauma- or cocaine-related memory approximately 120min after study medication was given.
Study NCT05902819 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Imagery
Description: Guided imagery of personal trauma- or cocaine-related memory approximately 120min after study medication was given.
Study NCT06231719 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Standard Injection Procedure
Description: Using any special method for injection
Study NCT06525922 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Center M
Description: Center M consists of weekly, 1-hour, telehealth, mindfulness-based Cognitive Behavioral Therapy (CBT) group sessions for four consecutive weeks. Participants joined group sessions on their personal computer, tablet, or phone. Each visit involved the introduction of a core mental well-being theme, learning skills to develop non-judgmental self-awareness and/or cognitive reappraisal skills, skills practice, and discussion of home practice materials. Home practice materials included written mindful awareness instructions, audio-guided meditations, self-compassion exercises, and practices in recognizing the interrelationships between thoughts, feelings, and behaviors.
Study NCT05902819 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Minocycline
Description: Single dose of minocycline (200mg) at each of two imagery sessions; Minocycline is given orally in form of a capsule.
Study NCT05902819 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Single dose of mannitol (100%) at each of two imagery sessions; Placebo is given orally in form of a capsule.
Study NCT04807751 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Delgocitinib cream
Description: Cream for topical application
Study NCT04807751 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Delgocitinib cream vehicle
Description: The cream vehicle is similar to the delgocitinib cream except that it does not contain any active ingredient.
Study NCT05763706 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Multiwave Locked System® (M6 laser, ASA srl, Arcugnano (VI), Italy)
Description: MLS® Laser M6 is a PBM device that allows the patients to be treated in various positions, either sitting, lying down or at a distance, without risk of contamination. Treatment times are carefully calibrated to deliver the best possible energy dose to the tissue being treated.
Study NCT04896034 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MILTA Device
Description: Patients in MILTA Device group will each receive 2 sessions of PBM in this study, the first session within 24 hours of delivery, and the second session 24 hours after the first session.
Study NCT05636202 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: There was no intervention in the retrospective study
Study NCT06303713 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Platinum coordination compound, premixed aqueous solution of 10mg/ML, via intravenous (into the vein) infusion per protocol.
Study NCT06303713 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 177Lu-PSMA-617
Description: Radioligand therapy, single-dose vial, via intravenous (into the vein) infusion per protocol.